Cardiome Pharma (CRME) CEO Janzen Leaves Company; Interim CEO Named
Tweet Send to a FriendGet Alerts CRME Hot Sheet
Trade CRME Now!
Cardiome Pharma Corp. (Nasdaq: CRME) announced that CEO Doug Janzen has left the Company.
Dr. William Hunter, a member of the Company's board of directors, has been appointed interim CEO.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Dr. William Hunter, a member of the Company's board of directors, has been appointed interim CEO.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Will Microsoft's (MSFT) Reorganization Lead to More Complex Structure?
- Duke Energy (DUK) Names Lynn Good as CEO
- Sempra Energy (SRE) Names Former Goldman (GS) Exec Kathleen Brown to Board
Create E-mail Alert Related Categories
Management Changes
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
